Roche continues to expect tariff impact on diagnostics despite U.S. deal
Source: SeekingAlpha
2026-03-07 11:37:01 ET
More on Roche Holding
- Roche Holding AG (RHHBY) Shareholder/Analyst Presentation
- Roche Holding AG (RHHBY) Shareholder/Analyst Call Transcript
- Roche Holding AG (RHHBY) Q4 2025 Earnings Call Transcript
- Roche succeeds in mid-stage trial for obesity drug developed with Zealand
- Roche CEO Schinecker wants a bite of the weight loss drugs market
Read the full article on Seeking Alpha
For further details see:
Roche continues to expect tariff impact on diagnostics despite U.S. deal
Roche Holding Ltd
NASDAQ: RHHBF
RHHBF Trading
-6.23% G/L:
$436.044 Last:
31 Volume:
$411.36 Open:
RHHBF Latest News
RHHBF Stock Data
$362,551,633,888
800,578,845
N/A
474
N/A
Pharmaceuticals
Healthcare
CH
Basel Switzerland
